AGW remaining following ablation
|
|
Experience or fear of local side‐effects in genital area
|
Explain how immunotherapy works
Advise patients that local side‐effects are a sign that the immune system has been activated and the therapy is working26, 30, 54, 66, 79
With imiquimod, explain that skin reactions are common and can sometimes be associated with adverse events (headache, fatigue, myalgia and nausea). Frequency of application may be reduced or treatment can be temporarily stopped if necessary79
|
Limited initial efficacy with imiquimod
|
Explain that some patients’ immune systems are slow to activate23, 56
Use an ablative method which can debulk and allow easier penetration
Reassure and continue with imiquimod
Inform the patient that some patients need the full 16‐week treatment course or even longer
|
Lack of adherence
|
Determine the extent to which the patient has adhered to the treatment regimen
Understand the reasons for lack of adherence (e.g., complicated regimen/side‐effects) and ensure the patient is provided with sufficient information about AGW and the different treatments that is clear and simple, both verbally and in written form8, 75, 79
Try an alternative therapy that is associated with better adherence/improved patient satisfaction26
|
Lumps left may not be true warts
|
|
Heavy cigarette smoking
|
|
Pregnancy
|
Explain that pregnancy is an immune suppressed state and therefore wart infections can become large during pregnancy but will usually disappear within weeks of delivery76
During pregnancy, the warts should not be treated if they do not represent an obstacle to delivery. If needed, only use ablative methods, e.g., cryotherapy or trichloroacetic acid3, 12, 50
Avoid extensive laser vaporization, electrocautery or surgery during the 6–8 weeks before delivery
Be aware that in rare cases, HPV can be transmitted during child birth resulting in recurrent respiratory papillomatosis in the infant73, 78
|
Immune suppression
|
Establish the patient's HIV status
Check to see whether they are on immunosuppressive drugs for inflammatory bowel disease, rheumatoid arthritis etc. Reassure the patient that clearance will still be achieved but it may take longer
|
Other conditions (i.e. diabetes, eczema, psoriasis)
|
Determine if the patient has other conditions, such as diabetes, which are associated with more extensive AGW and recurrences that may require prolonged treatment80
More ablation and prolonged imiquimod courses may be required
It is recommended not to use imiquimod if there is eczema, psoriasis or other dermatoses in the genital area77
|
Concomitant local infections (e.g. bacterial, fungal etc.)
|
|